Use cases across the evidence lifecycle

Where CLEVAIR supports value across strategy, evidence, drafting, and follow-through

CLEVAIR-HTA helps teams manage upstream planning, submission execution, and downstream national follow-through in one connected working model.

Lifecycle view

Typical entry points by lifecycle stage and team

Lifecycle stage Team Typical challenge Where CLEVAIR helps
Pre-Phase 3 / Phase 2 Market access / HEOR / evidence planning Teams need earlier PICO shaping, comparator logic, and evidence-gap visibility before scope hardens. Use CLEVAIR to strengthen evidence strategy before formal dossier work begins.
Phase 3 design Cross-functional evidence team Study design and evidence generation decisions are made without a clear downstream HTA execution frame. Test comparators, outcomes, subpopulations, and evidence gaps earlier.
Pre-JCA / submission prep Evidence, regulatory, and medical writing Sources, drafting, and review are fragmented across tools and handoffs. Keep evidence operations, drafting, and controlled review in one workflow.
Post-JCA / national launch Local access and affiliate teams The EU report is done, but local dossier support and payer responses still need structured follow-through. Extend governed execution beyond the JCA handoff into national work.
Best fit

Best suited to teams that already understand HTA methodology and now need a more disciplined way to execute it

Especially relevant when comparator logic, evidence retrieval, draft content, and review decisions need to stay connected across the workflow.

Most relevant when the buyer wants continuity across strategy, evidence, drafting, and review rather than another isolated tool.

Request a demo

See whether CLEVAIR fits your current HTA workflow

Show us where your team is facing delay, duplication, comparator complexity, evidence pressure, or review friction. We will tailor the discussion around the part of your workflow that needs the most support first.